Skip to main content
. 2012 Nov 21;75(6):1433–1444. doi: 10.1111/bcp.12042

Figure 2.

Figure 2

Whole blood platelet aggregation by VerifyNow P2Y12 in healthy subjects and patients with SCD before and after prasugrel treatment. P2Y12 reactivity units (A) before initiation of prasugrel treatment and following 12 days of prasugrel treatment and device-reported and calculated percentage inhibition (B) following 12 days of prasugrel treatment in healthy subjects (n = 13) and in patients SCD (n = 13). Inline graphic, baseline; Inline graphic, day 12